Welsh, Carson, Anderson & Stowe Announces Formation of Valtruis, a New Value-Driven Care Holding Company, with Initial Commitment of $ 300 Million
NEW YORK, August 3, 2021 / PRNewswire / – Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and tech industries, today announced the launch of Valtruis, a unique holding company that will invest in and partner with healthcare companies whose mission is to realign and transform healthcare in the United States with the principles of value-based care. WCAS hires a first $ 300 million to this platform.
Building on WCAS ’40 years of experience and its close relationships within the healthcare ecosystem, Valtruis builds a set of exclusive capabilities that leverage and accelerate innovation in healthcare through partner companies of Valtruis.
The founding management team of Valtruis includes the Managing Partners Anna Haghgooie, Tracy bahl and Witty Karey, who have collectively played a role in the growth of many disruptive and market-leading healthcare companies as operators and investors throughout their respective careers.
- Ms. Haghgooie was until recently Managing Director of Blue Venture Fund and Sandbox Industries, where she worked with numerous tech and healthcare companies, including four start-ups.
- Mr. Bahl previously served as President and CEO of OneOncology, a leading network of community-based oncology practices in the United States. Prior to OneOncology, Mr. Bahl was Executive Vice President of Health Plans for CVS Health; Executive Chairman of Emdeon and CEO of Uniprise, a UnitedHealth group company.
- Mr. Witty most recently served as COO of Envision Healthcare, a provider of advanced practice medicine and services to healthcare facilities in the United States. of HealthSpring and CFO of Centene Corp.
David Caluori, General Partner at WCAS, said, “We are very pleased to announce the creation of Valtruis and are delighted to be working with Anna, Tracy and Karey to partner with transformative companies in the US healthcare ecosystem. We believe that Valtruis is well positioned to take advantage of the benefits of WCAS. long-standing relationships and history of building market-leading healthcare companies, as well as exceptional talent and operating expertise to provide a differentiated resource for emerging companies looking to accelerate adoption of value-based care. “
Anna haggooie, Managing Partner of Valtruis, added “For more than 40 years, WCAS has partnered with healthcare companies to grow, innovate and create value. We look forward to continuing this tradition with Valtruis, supporting companies focused on long-term growth and momentum to reduce costs, expand access and increase quality with our capital and expertise.
Over the past four decades, WCAS has successfully invested approximately 10 billion dollars of the capital of more than 90 healthcare companies through its 13 private equity funds. WCAS’s current portfolio includes market-leading healthcare companies such as CenterWell and InnovAge.
Valtruis, a WCAS portfolio company, provides a unique platform that invests and partners with disruptive leaders whose mission is to align and transform healthcare through truly value-driven care. Founded on a commitment to accelerate significant change, Valtruis brings the functional expertise, access to capital and a vast network that advance the evolution of our partners, from early development to leading companies in the sector. Together, Valtruis and its partner companies will cross systemic barriers in the healthcare sector to reduce costs, expand access, increase quality and radically improve the patient experience. Learn more about valtruis.com.
About Welsh, Carson, Anderson & Stowe
WCAS is a leading US private equity firm focused on two target industries: technology and healthcare. Since its founding in 1979, the company’s strategy has been to partner with exceptional management teams and create value for its investors through a combination of operational improvements, growth initiatives and strategic acquisitions. . The company has raised and managed funds totaling more than $ 27 billion of committed capital. For more information, please visit wcas.com.
SOURCE Welsh, Carson, Anderson & Stowe